Cargando…

Bilateral stellate ganglion block for migraine: A case report

RATIONALE: Migraine is a recurrent, disabling neurovascular headache disorder. The patient's quality of life can be severely impaired by migraine attacks. Stellate ganglion block (SGB) can be used to relieve pain in the head, neck, and upper extremities. In the present cases, we performed SGB i...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Suyoung, Lee, Joonhee, Jeon, Younghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440256/
https://www.ncbi.nlm.nih.gov/pubmed/32358380
http://dx.doi.org/10.1097/MD.0000000000020023
Descripción
Sumario:RATIONALE: Migraine is a recurrent, disabling neurovascular headache disorder. The patient's quality of life can be severely impaired by migraine attacks. Stellate ganglion block (SGB) can be used to relieve pain in the head, neck, and upper extremities. In the present cases, we performed SGB in 2 patients with migraine that responds poorly to drugs. PATIENT CONCERNS: Patients 1 and 2 suffered from chronic, bilateral pulsating headache, accompanied by nausea and vomiting. Patient 1 presented with headache of 8 on the visual analog scale (VAS), and 37 on the migraine disability assessment (MIDAS). Patient 2 reported headache of 7 on the VAS, and 32 on the MIDAS. DIAGNOSIS: The patients were diagnosed with migraine without aura based on the International Classification of Headache Disorders version 3. INTERVENTIONS: Patient 1 was treated with bilateral SGB every week for a month and then every month for 3 months. Patient 2 received bilateral SGB every 2 weeks for a month and then every month for 3 months. OUTCOMES: Four months after SGB, patient 1 reported pain intensity of 4 on VAS and 6 on MIDAS and patient 2 rated pain intensity of 3 on VAS, and 6 on MIDAS, respectively. LESSONS: The SGB can be an effective option to improve headache-related disability and relieve pain intensity in the patients with refractory migraine.